Millennium Pharmacon (Indonesia) Probability of Future Stock Price Finishing Over 94.0
| SDPC Stock | IDR 147.00 5.00 3.52% |
Millennium |
Millennium Pharmacon Target Price Odds to finish over 94.0
The tendency of Millennium Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay above 94.00 in 90 days |
| 147.00 | 90 days | 94.00 | close to 99 |
Based on a normal probability distribution, the odds of Millennium Pharmacon to stay above 94.00 in 90 days from now is close to 99 (This Millennium Pharmacon International probability density function shows the probability of Millennium Stock to fall within a particular range of prices over 90 days) . Probability of Millennium Pharmacon price to stay between 94.00 and its current price of 147.0 at the end of the 90-day period is about 31.09 .
Assuming the 90 days trading horizon Millennium Pharmacon International has a beta of -0.57. This usually implies as returns on the benchmark increase, returns on holding Millennium Pharmacon are expected to decrease at a much lower rate. During a bear market, however, Millennium Pharmacon International is likely to outperform the market. Additionally Millennium Pharmacon International has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite. Millennium Pharmacon Price Density |
| Price |
Predictive Modules for Millennium Pharmacon
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Millennium Pharmacon. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Millennium Pharmacon's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Millennium Pharmacon Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Millennium Pharmacon is not an exception. The market had few large corrections towards the Millennium Pharmacon's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Millennium Pharmacon International, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Millennium Pharmacon within the framework of very fundamental risk indicators.α | Alpha over NYSE Composite | -0.12 | |
β | Beta against NYSE Composite | -0.57 | |
σ | Overall volatility | 5.85 | |
Ir | Information ratio | -0.11 |
Millennium Pharmacon Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Millennium Pharmacon for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Millennium Pharmacon can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Millennium Pharmacon generated a negative expected return over the last 90 days | |
| Millennium Pharmacon has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| Millennium Pharmacon International has accumulated about 43.62 B in cash with (18.18 B) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 34.24. | |
| Roughly 88.0% of the company outstanding shares are owned by corporate insiders |
Millennium Pharmacon Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Millennium Stock often depends not only on the future outlook of the current and potential Millennium Pharmacon's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Millennium Pharmacon's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.3 B | |
| Cash And Short Term Investments | 47.4 B |
Millennium Pharmacon Technical Analysis
Millennium Pharmacon's future price can be derived by breaking down and analyzing its technical indicators over time. Millennium Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Millennium Pharmacon International. In general, you should focus on analyzing Millennium Stock price patterns and their correlations with different microeconomic environments and drivers.
Millennium Pharmacon Predictive Forecast Models
Millennium Pharmacon's time-series forecasting models is one of many Millennium Pharmacon's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Millennium Pharmacon's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Millennium Pharmacon
Checking the ongoing alerts about Millennium Pharmacon for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Millennium Pharmacon help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Millennium Pharmacon generated a negative expected return over the last 90 days | |
| Millennium Pharmacon has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| Millennium Pharmacon International has accumulated about 43.62 B in cash with (18.18 B) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 34.24. | |
| Roughly 88.0% of the company outstanding shares are owned by corporate insiders |
Check out Millennium Pharmacon Backtesting, Millennium Pharmacon Valuation, Millennium Pharmacon Correlation, Millennium Pharmacon Hype Analysis, Millennium Pharmacon Volatility, Millennium Pharmacon History as well as Millennium Pharmacon Performance. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Millennium Stock analysis
When running Millennium Pharmacon's price analysis, check to measure Millennium Pharmacon's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Millennium Pharmacon is operating at the current time. Most of Millennium Pharmacon's value examination focuses on studying past and present price action to predict the probability of Millennium Pharmacon's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Millennium Pharmacon's price. Additionally, you may evaluate how the addition of Millennium Pharmacon to your portfolios can decrease your overall portfolio volatility.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |